Guggenheim Securities
Guggenheim Securities is the New York-based investment banking and capital markets division of privately held Guggenheim Partners. As of 2026, its equity research teams cover about 380 companies in consumer, healthcare, internet and media, power and energy transition, and technology.
Activity24M
RatingsPrice targetsKey figures
- Stocks covered
- 37912M
- Actions
- 1,44412M
- Ratings / Price targets
- 871 / 573
- Upgrades / Downgrades
- 27 / 36
- Initiations
- 51
- Buy-rated
- 82%of 354 rated
- Median upside
- +26.9%
- Targets raised / lowered
- 285 / 131
- On record
- Dec 2011 – Sep 2026
Overview
Its equity research analysts average 18 years of Wall Street and industry experience. Signature products include the Guggenheim 360° series, Data Insights built on alternative data, and Grand Rounds interviews with physicians and scientists for healthcare investors. In 2026 it published The Century Project, a 210-page longevity study co-written by Stefano Natella.
Guggenheim Partners was founded in 1999 in partnership with the Guggenheim family, whose business dates to the late 1800s. Its broker-dealer, formerly Links Securities and Guggenheim Capital Markets, focused on fixed income sales and trading until former Bear Stearns CEO Alan Schwartz joined as executive chairman in 2009 to build a full-service investment bank. In 2018 it agreed to acquire restructuring adviser Millstein & Co., whose founder Jim Millstein became co-chairman. It has more than 1,100 professionals as of 2026.
Milestones
- 1999
Guggenheim Partners founded with the Guggenheim family
- 2009
Alan Schwartz joined to build a full-service investment bank
- 2018
Agreed to acquire restructuring adviser Millstein & Co.
Firm facts
- Legal name
- Guggenheim Securities, LLC
- Type
- Full-service
- Founded
- 1999
- Headquarters
- New York, United States
- Parent
- Guggenheim Partners
- Chief Executive Officer
- Mark Van Lith
- Rating scale
- BuyNeutralSell12 months
- Also filed as
- Guggenheim
- Website
- guggenheimsecurities.com
Research philosophy
Rigorous primary research is central to our approach.
Guggenheim Securities combines primary research with investment ideas, access to company management and insights from experts across disciplines. When Stefano Natella joined to lead research in 2017, co-CEO Jerry Donini described a shared "unwavering commitment to the value of high-quality content."
Rating methodology
Its 12-month ratings are Buy for an expected total return of at least 10%, Neutral for a return between −10% and +10%, and Sell for a loss of at least 10%.
Coverage12M
Sectors
Most covered24M
| Stock | Rating | Target |
|---|---|---|
 Sphere Entertainment Co.SPHR | Buy | $208 |
 Spotify Technology S.A.SPOT | Buy | $565 |
 Johnson & JohnsonJNJ | Buy | $287 |
 Eli Lilly and CompanyLLY | Buy | $1,284 |
 Oracle CorporationORCL | Buy | $400 |
 Netflix, Inc.NFLX | Buy | $75 |
 Revolution Medicines, Inc.RVMD | Buy | $275 |
 Target CorporationTGT | Buy | $175 |
 AbbVie Inc.ABBV | Buy | $288 |
 MongoDB, Inc.MDB | Buy | $560 |
Most active analysts
- Curry Baker38 notesMSGSSTUBMSGE
- Yatin Suneja30 notesAXSMALMSANAB
- John Heinbockel23 notesDGFIVEKR
- Joseph Osha22 notesGEVENPHMTZ
- Michael Morris22 notesTTDNFLXFOXA
- Subbu Nambi21 notesBRKRCYRXCSTL
Recent actions
| Date | Stock | Rating action | Rating | Target | Analyst |
|---|---|---|---|---|---|
| Sep 21 | BLBlossomHill Therapeutics, Inc.BLSM | Reiterate | Buy | $30 →$40 | |
| Sep 21 |  Lowe's Companies, Inc.LOW | Reiterate | Buy | ||
| Sep 21 |  Autodesk, Inc.ADSK | Reiterate | Buy | ||
| Sep 18 | DTDynatrace, Inc.DT | Downgrade | Neutral | ||
| Sep 18 |  Restaurant Brands International Inc.QSR | Reiterate | Buy | $85 →$86 | |
| Sep 18 | Eli Lilly and CompanyLLY | Reiterate | Buy | $1,273 →$1,284 | Seamus Fernandez |
| Sep 18 |  The Trade Desk, Inc.TTD | Target | $12 →$13 | Michael Morris | |
| Sep 18 | SISirius XM Holdings Inc.SIRI | Reiterate | Buy | ||
| Sep 18 |  Accenture plcACN | Downgrade | Buy →Neutral |